Status:
UNKNOWN
Postoperative Sequence Chemoradiotherapy Compared With Chemotherapy Alone for Advanced Gastric Cancer
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
Gastric cancer is one of the most prevalent malignancies in China; the survival rate remains poor despite potentially curative resections. Complete surgical resection is the only potentially curative ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Postoperative histologically confirmed advanced adenocarcinoma of the stomach or the gastroesophageal junction.
- Age of 18 to 75, Karnofsky score higher than 70.
- Postoperative histologically conformed metastasis in perigastric lymph nodes and/or tumor invasion to muscularis propria or subserosa, with or without positive incisal margin.
- No severe functional damage of major organ, normal blood cell, normal liver and kidney function.
- No clinical findings of distant metastasis.
- Predictive survival time longer than 6 months.
Exclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01197118
Start Date
September 1 2010
End Date
May 1 2011
Last Update
September 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Cancer Center,Tongji Hospital
Wuhan, Hubei, China, 430030